Failure of acute rejection reversal · kidney transplant recipients: first rejection episode
Antibody (T cell) probably leads to lower failure of reversal of acute rejection compared with steroid (stratified by antibody type) (moderate certainty).
1 finding from 1 review
Recurrent rejection · kidney transplant recipients: first rejection episode
Antibody (T cell) showed no clear difference in recurrent rejection compared with steroid (stratified by antibody type) (moderate certainty).
1 finding from 1 review
Graft loss or death with a functioning graft · kidney transplant recipients: first rejection episode
Antibody (T cell) showed no clear difference in graft loss or death with a functioning graft compared with steroid (stratified by antibody type) (low certainty).
1 finding from 1 review
Graft loss censored for death · kidney transplant recipients: first rejection episode
Antibody (T cell) showed no clear difference in graft loss censored for death compared with steroid (stratified by antibody type) (low certainty).
1 finding from 1 review
Death · kidney transplant recipients: first rejection episode
It is very uncertain whether antibody (T cell) changes death compared with steroid (stratified by antibody type) (very low certainty).
1 finding from 1 review
Treatment adverse events: fever, chills, malaise after drug administration · kidney transplant recipients: first rejection episode
It is very uncertain whether antibody (T cell) changes treatment adverse events: fever, chill, or malaise after drug… compared with steroid (stratified by antibody type) (very low certainty).
1 finding from 1 review
All‐cause mortality · lung transplant recipients
T‐cell antibody induction showed no clear difference in mortality compared with no antibody induction (moderate certainty).
1 finding from 1 review
Acute rejection grade II or higher · lung transplant recipients
T‐cell antibody induction showed no clear difference in acute rejection grade II or higher compared with no antibody induction (moderate certainty).
1 finding from 1 review
Infection · lung transplant recipients
T‐cell antibody induction showed no clear difference in infection compared with no antibody induction (moderate certainty).
1 finding from 1 review
Bronchiolitis obliterans syndrome · lung transplant recipients
T‐cell antibody induction showed no clear difference in bronchiolitis obliterans syndrome compared with no antibody induction (moderate certainty).
1 finding from 1 review
All‐cause mortality · lung transplant recipients
Polyclonal T‐cell antibody showed no clear difference in mortality compared with no antibody induction (moderate certainty).
1 finding from 1 review
Acute rejection grade II or higher · lung transplant recipients
Polyclonal T‐cell antibody showed no clear difference in acute rejection grade II or higher compared with no antibody induction (moderate certainty).
1 finding from 1 review
Infection · lung transplant recipients
Polyclonal T‐cell antibody showed no clear difference in infection compared with no antibody induction (moderate certainty).
1 finding from 1 review
Bronchiolitis obliterans syndrome · lung transplant recipients
Polyclonal T‐cell antibody showed no clear difference in bronchiolitis obliterans syndrome compared with no antibody induction (moderate certainty).
1 finding from 1 review
All‐cause mortality · lung transplant recipients
Polyclonal T‐cell antibody induction showed no clear difference in mortality compared with interleukin‐2 receptor antagonist induction (moderate certainty).
1 finding from 1 review
Acute rejection · lung transplant recipients
Polyclonal T‐cell antibody induction showed no clear difference in acute rejection compared with interleukin‐2 receptor antagonist induction (moderate certainty).
1 finding from 1 review
Infection · lung transplant recipients
Polyclonal T‐cell antibody induction showed no clear difference in infection compared with interleukin‐2 receptor antagonist induction (moderate certainty).
1 finding from 1 review
Bronchiolitis obliterans syndrome · lung transplant recipients
Polyclonal T‐cell antibody induction showed no clear difference in bronchiolitis obliterans syndrome compared with interleukin‐2 receptor antagonist induction (moderate certainty).
1 finding from 1 review
Graft loss censored for death · kidney transplant recipients: first rejection episode
It is very uncertain whether antibody (T cell) + steroid changes graft loss censored for death compared with steroid alone (very low certainty).
1 finding from 1 review
Death · kidney transplant recipients: first rejection episode
Antibody (T cell) + steroid showed no clear difference in death compared with steroid alone (low certainty).
1 finding from 1 review